XV International HIV Drug Resistance Workshop

Organizing Committee

Brendan Larder, Chair
RDI, UK

Charles Boucher, Co-chair
University Hospital Utrecht, The Netherlands

John Mellors
University of Pittsburgh, USA

Douglas Richman
University of California San Diego/VA Medical Center, USA

Scientific Committee

Lee Bacheler
Virco Lab, Inc., USA

Nick Cammack
Roche Palo Alto, USA

François Clavel
Inserm U552, France

Bonaventura Clotet
Fundacio IRSI Caixa, Spain

John Coffin
National Cancer Institute-Frederick, USA

Dominique Costagliola
INSERM 0214, France

Victor De Gruttola
Harvard School of Public Health, USA

Robert Grant
Gladstone/UCSF, USA

Michael Greenberg
Trimeris, Inc, USA

Richard Harrigan
BC Centre For Excellence in HIV/AIDS, Canada

Daria Hazuda
Merck Research Laboratories, USA

Nicholas Hellmann
Bill & Melinda Gates Foundation, USA

Kurt Hertogs
Tibotec BVBA, Belgium

Dale Kempf
Abbott Laboratories, USA

Daniel Kuritzkes
Brigham and Women's Hospital, USA

Randall Lanier
GlaxoSmithKline, USA

Susan Little
University of California, San Diego, USA

Douglas Mayers
Boehringer Ingelheim Pharmaceuticals, Inc, USA

Michael Miller
Gilead Sciences, USA

Michael Parniak
University of Pittsburgh, USA

Luc Perrin
Geneva University Hospital, Switzerland

Christos Petropoulos
Monogram Biosciences, Inc.

Deenan Pillay
Royal Free and University College Medical School, UK

Jonathan Schapiro
Stanford University, USA

Raymond Schinazi
Emory University/VA Medical Center, USA

David Stammers
University of Oxford, UK

Mark Wainberg
McGill University AIDS Centre, Canada

Mike Westby
Pfizer Global R&D, UK

Rainer Ziermann
Bayer Healthcare Diagnostics, USA



						Organizing Committee Brendan Larder, Chair RDI, UK Charles Boucher, Co-chair University Hospital Utrecht, The Netherlands John Mellors University of Pittsburgh, USA Douglas Richman University of California San Diego/VA Medical Center, USA Scientific Committee Lee Bacheler Virco Lab, Inc., USA Nick Cammack Roche Palo Alto, USA François Clavel Inserm U552, France Bonaventura Clotet Fundacio IRSI Caixa, Spain John Coffin National Cancer Institute-Frederick, USA Dominique Costagliola INSERM 0214, France Victor De Gruttola Harvard School of Public Health, USA Robert Grant Gladstone/UCSF, USA Michael Greenberg Trimeris, Inc, USA Richard Harrigan BC Centre For Excellence in HIV/AIDS, Canada Daria Hazuda Merck Research Laboratories, USA Nicholas Hellmann Bill & Melinda Gates Foundation, USA Kurt Hertogs Tibotec BVBA, Belgium Dale Kempf Abbott Laboratories, USA Daniel Kuritzkes Brigham and Women's Hospital, USA Randall Lanier GlaxoSmithKline, USA Susan Little University of California, San Diego, USA Douglas Mayers Boehringer Ingelheim Pharmaceuticals, Inc, USA Michael Miller Gilead Sciences, USA Michael Parniak University of Pittsburgh, USA Luc Perrin Geneva University Hospital, Switzerland Christos Petropoulos Monogram Biosciences, Inc. Deenan Pillay Royal Free and University College Medical School, UK Jonathan Schapiro Stanford University, USA Raymond Schinazi Emory University/VA Medical Center, USA David Stammers University of Oxford, UK Mark Wainberg McGill University AIDS Centre, Canada Mike Westby Pfizer Global R&D, UK Rainer Ziermann Bayer Healthcare Diagnostics, USA Copyright © 2006 Informed Horizons, LLC All rights reserved, additional copyright information also applies.